Metacognitive Reflection & Insight Therapy (MERIT)

Not Applicable

Completed

• Conditions: Schizophrenia, metacognitive deficits; Mental and Behavioural Disorders; Schizophrenia, unspecified

• Registration Number: ISRCTN16659871
• Lead Sponsor: niversity of Groningen (Netherlands)

Brief Summary

2014 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/24490942 protocol 2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29692285 results (added 20/06/2019)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-03-20
• Study Completion: 2015-05-01
• Last Update Posted: 21 March 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

1. A diagnosis of schizophrenia according to Diagnostic and Statistical Manual of Mental Disorders, 4th edition text revision (DSM-IV-TR) criteria
2. Impaired metacognitive skills
3. Being able to give informed consent
4. Men and women,18- 65 years old
5. No change in medication in the past thirty days

Exclusion Criteria

1. Florid psychosis (mean positive symptoms <4 measured by PANSS)
2. Co-morbid neurological disorder
3. Substance dependence (not substance abuse)
4. IQ <70

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Metacognitive functioning, which will be assessed using the Metacognitive Assessment Scale (MAS-NL)<br><br> The post-treatment assessment is ten months after the baseline assessment; the follow-up assessment is six months after the post-treatment assessment.<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. Beck Depression Inventory (BDI-II)<br> 2. Manchester Short Assessment of Quality of Life (MANSA)<br> 3. Internalized Stigma of Mental Illness scale (ISMI)<br> 4. Time Use<br> 5. PSP and SF-12 (social functioning)<br> 6. Positive and Negative Symptom Scale (PANSS)<br> 7. Schedule for Assessment of Insight (SAI-E) Trailmaking Test A en B<br> 8. Digit Symbol Task (WAIS I subtest)<br> 9. Interpersonal Reactivity Index (IRI)<br> 10. Faux Pas test<br> 11. Empathic Accuracy Test<br> 12. Work Readiness Questionnaire (WORQ)<br> 13. Clinical Impression (CGI)<br> 14. Care consumption list (zorgconsumptielijst)<br><br> The post-treatment assessment is ten months after the baseline assessment; the follow-up assessment is six months after the post-treatment assessment.<br>